Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,956	2,067	2,332	2,296	1,488
Other Revenue	-	47.17	108.67	67.67	9.49
Revenue	2,956	2,114	2,441	2,363	1,497
Revenue Growth (YoY)	39.84%	-13.39%	3.28%	57.86%	-21.87%
Cost of Revenue	2,409	1,535	1,612	1,526	808.77
Gross Profit	547.04	579.23	829.2	837.21	688.42
Selling, General & Admin	-	221.61	232.28	175.11	143.25
Research & Development	-	189.13	187.71	133.53	84.3
Other Operating Expenses	-	9.21	-4.09	22.94	10.45
Operating Expenses	-	413.68	422.59	337.95	241.23
Operating Income	547.04	165.55	406.61	499.25	447.19
Interest Expense	-	-32.17	-20.01	-16.29	-3.86
Interest & Investment Income	-	219.77	236.78	229.61	52.18
Earnings From Equity Investments	-	-7.82	-3.71	-	-
Currency Exchange Gain (Loss)	-	29.59	82.97	-14.14	-18.26
Other Non Operating Income (Expenses)	-1.31	-5.7	-4.61	-0.59	-0.32
EBT Excluding Unusual Items	545.74	369.22	698.03	697.84	476.93
Gain (Loss) on Sale of Investments	-	-	-	-	9.15
Gain (Loss) on Sale of Assets	-	-0.01	0.07	-	-
Asset Writedown	-	-0.26	-0.02	-0.06	-1.15
Other Unusual Items	-	79.97	-2.09	26.66	35.85
Pretax Income	545.74	448.92	695.99	724.45	520.79
Income Tax Expense	59.01	40.39	83.34	90.94	63.45
Earnings From Continuing Operations	486.73	408.54	612.65	633.51	457.34
Minority Interest in Earnings	-	-42.01	-59.39	-38.79	0.33
Net Income	486.73	366.52	553.27	594.72	457.67
Net Income to Common	486.73	366.52	553.27	594.72	457.67
Net Income Growth	32.80%	-33.75%	-6.97%	29.94%	-4.43%
Shares Outstanding (Basic)	579	582	582	583	543
Shares Outstanding (Diluted)	579	582	582	583	543
Shares Change (YoY)	-0.40%	-0.10%	-0.11%	7.38%	6.91%
EPS (Basic)	0.84	0.63	0.95	1.02	0.84
EPS (Diluted)	0.84	0.63	0.95	1.02	0.84
EPS Growth	33.33%	-33.68%	-6.86%	21.01%	-10.61%
Free Cash Flow	-	-1,000	-3,395	-880.49	-248.15
Free Cash Flow Per Share	-	-1.72	-5.83	-1.51	-0.46
Dividend Per Share	-	0.190	0.180	0.321	0.571
Dividend Growth	-	5.56%	-43.99%	-43.75%	-
Gross Margin	18.50%	27.40%	33.97%	35.42%	45.98%
Operating Margin	18.50%	7.83%	16.66%	21.12%	29.87%
Profit Margin	16.46%	17.34%	22.66%	25.16%	30.57%
Free Cash Flow Margin	-	-47.32%	-139.06%	-37.25%	-16.57%
EBITDA	827.99	446.49	671.73	667.79	565.51
EBITDA Margin	28.01%	21.12%	27.52%	28.25%	37.77%
D&A For EBITDA	280.95	280.95	265.12	168.54	118.32
EBIT	547.04	165.55	406.61	499.25	447.19
EBIT Margin	18.50%	7.83%	16.66%	21.12%	29.87%
Effective Tax Rate	10.81%	9.00%	11.97%	12.55%	12.18%
Revenue as Reported	-	2,114	2,441	2,363	1,497

Source: S&P Global Market Intelligence. Standard template. Financial Sources.